Risk estimation for breast cancer development; a clinical perspective

Surgical Oncology

Volumn 10, Issue 4, 2002, Pages 183-192

  Sakorafas, George H ^a,b   Krespis, Eustathios ^a   Pavlakis, George ^a  

^a 251 GENERAL AIR FORCE HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Breast cancer; Chemoprevention; Prophylactic mastectomy; Risk factors; Surveillance; The Claus model; The Gail model

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

AGE; BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CARCINOMA IN SITU; CHEMOPROPHYLAXIS; DISEASE COURSE; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; MASTECTOMY; MENARCHE; MENOPAUSE; OCCULT CANCER; ORAL CONTRACEPTION; PATIENT COUNSELING; PREDICTION; PREGNANCY; PRIORITY JOURNAL; RADIATION EXPOSURE; REPRODUCTION; REVIEW; RISK ASSESSMENT;

EID: 0036097718     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(02)00016-6     Document Type: Short Survey

References (76)

1. Cancer statistics
2. Recent trends in US breast cancer incidence, survival, and mortality rates
3. Breast cancer risk assessment: Who holds the magic crystal ball?
4. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
5. Identification and management of women at increased risk for breast cancer development
6. Management of the high risk and the concerned patient
7. Genetic predisposition to breast cancer: A surgical perspective
8. Surveillance, epidemiology, and end results [SEER]; Breast cancer-current trends in diagnosis and treatment
9. Reproductive factors and breast cancer
10. Breast cancer
11. Breast cancer prevention: A review of current evidence
12. A review of the epidemiology of human breast cancer
13. Risk of breast cancer among young women: Relationship to induced abortion
14. Is "fibrocystic disease" of the breast pre-cancerous?
15. The woman at increased risk for breast cancer: Evaluation and management strategies
16. Risk factors for breast cancer in women with proliferative breast disease
17. Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease
18. Risk of invasive cancer in women with lobular carcinoma in situ of the breast
19. Lobular carcinoma in situ of the female breast: The Danish Breast Cancer Cooperative Group: Short term results of a prospective nationwide study
20. Borderline epithelial lesions of the breast
21. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast
22. The clinical significance of pre-invasive breast carcinoma
23. Management of ductal carcinoma in situ
24. Ductal carcinoma in situ. A shared experience of two single institutional nonrandomized prospective studies
25. Optimal management of primary breast cancer
26. The current role of prophylactic mastectomy
27. Contralateral breast cancer: Clinical characteristics and impact on prognosis
28. Contralateral breast carcinoma: An assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20 year follow-up
29. Bilateral breast cancer
30. Risk of cancer in BRCA1 mutation carriers
31. The genetic epidemiology of second primary cancer
32. Cancer in the contralateral breast after radiotherapy for breast cancer
33. Multicentricity and bilaterality in invasive breast carcinoma
34. Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer
35. Bilateral primary breast cancers. A prospective clinicopathologic study
36. Evaluation of the contralateral breast
37. Synchronous, bilateral mastectomy
38. Bilateral and multifocal breast carcinoma
39. Subcutaneous mastectomy data: An interim report
40. Breast cancer, subcutaneous mastectomy, breast reconstruction
41. Contralateral cancerous breast lesions in women with clinically invasive breast carcinoma
42. Mammary cancer: The other breast
43. Pathology and heredity of breast cancer in younger women
44. What can a woman do about her risk of dying from breast cancer?
45. Risk of familial breast cancer
46. Breast cancer genes
47. Genetic testing for cancer susceptibility
48. Prophylactic mastectomy for genetic predisposition to breast cancer: The proband's story
49. Exogenous hormone use and the risk of postmenopausal breast cancer
50. Breast cancer, hormonal contraceptives
51. The estimated effect of oran contraceptive use on the cumulative risk of epithelial ovarian cancer
52. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis
53. Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age
54. Epidemiology, prevention, and early detection of breast cancer
55. Autosomal dominant inheritance of early onset breast cancer: Implications for risk prediction
56. Risk of familial breast cancer
57. Practical guide for estimating risk for familial breast cancer
58. Validation of a breast cancer risk assessment model in women with a positive family history
59. Validation studies for models projecting the risk of invasive and total breast cancer incidence
60. Assessing the risk of breast cancer in individuals
61. Validation of the Gail et al. model for predicting individual breast cancer risk
62. From adjuvant therapy to breast cancer prevention: BCPT and STAR
63. Assessing the risk of breast cancer
64. Prophylactic mastectomy; Evolving perspectives
65. Living in a high-risk family
66. Mammography adherence and psychological distress among women at risk for breast cancer
67. Ductal carcinoma in situ of the breast; Evolving perspectives
68. Oncogenes and cancer. The genetic basis of cancer
69. The chemoprevention of cancer
70. The women at high-risk for breast cancer development; preventive strategies
71. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
72. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the more randomized trial. Multiple outcomes of raloxifene evaluation
73. Decision analysis - Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations
74. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients
75. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
76. Can breast cancer risk be modified by diet?